| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vifa2g03356 | ATGGAAACTGTGAGCACTGAACCATCAAAACCAGAATTGGATTCCAATCAAGATGAAGCAAAAGCTCAAGTTGTTGTTGTTCAAGATGATGGAGCTTTGAAAGACAGCACAGAAGCAGAGCTCAAGAAAATCAGTCTCATGAGAACTTTTGTTGAAGCCCGCGACCCTTCTTCTAAGGAAGTAGATGATTTGATGATAAGAAGATTCTTGAGAGCTCGTGATTTAGATGTAGAGAAATCTTCAGCTATGTTCCTGAAGTACTTGAAATGGAAGCATTCATTTGTTCCAAATGGGTCTGTTTCGCCTTCGGAGATTCGTGGTGATCTTGCACAGGAGAAGATGTATGTTCAAGGAGTGGATAAAAAGGGTCGACCTATAACTGTTGCATTTGCTGCTAAACATTTTCAAAACAAAAATGGTTTGGAAGCATTCAAACGGTATGTAGTTTTTGCGCTTGAGAAACTATGTTCAAGGATGCCACCGGGGGAAGAAAAGTTTCTTGCTATTGCAGATATTAAGGGATGGGGATATGCAAACAGTGACCTTCGTGGATACCTTGGTGCTCTAACAATTCTGCAGGATTACTATCCAGAGAGATTGGGAAAATTGTTCATAGTTCATGCACCTTACATGTTTATGAAAGTATGGAAACTTGTATACCCTTTCATTGATGACAATACCAAGAAAAAGATAGTATTTGTGGATAACAAGAAGCTGAAATCGACATTGTTAGAAGAGATCGATGAGAGTCAGCTCCCGGAGATATATGGAGGCAAACTTCAACTAGTTCCAATACAGCATTCATGA | 807 | 0.3953 | METVSTEPSKPELDSNQDEAKAQVVVVQDDGALKDSTEAELKKISLMRTFVEARDPSSKEVDDLMIRRFLRARDLDVEKSSAMFLKYLKWKHSFVPNGSVSPSEIRGDLAQEKMYVQGVDKKGRPITVAFAAKHFQNKNGLEAFKRYVVFALEKLCSRMPPGEEKFLAIADIKGWGYANSDLRGYLGALTILQDYYPERLGKLFIVHAPYMFMKVWKLVYPFIDDNTKKKIVFVDNKKLKSTLLEEIDESQLPEIYGGKLQLVPIQHS | 268 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vifa2g03356 | 268 | MobiDBLite | consensus disorder prediction | 1 | 21 | - | - | |
| Vifa2g03356 | 268 | Pfam | CRAL/TRIO domain | 112 | 258 | IPR001251 | - | |
| Vifa2g03356 | 268 | SMART | sec14_4 | 108 | 261 | IPR001251 | - | |
| Vifa2g03356 | 268 | Gene3D | - | 1 | 267 | IPR036865 | - | |
| Vifa2g03356 | 268 | SUPERFAMILY | CRAL/TRIO domain | 104 | 261 | IPR036865 | - | |
| Vifa2g03356 | 268 | CDD | SEC14 | 115 | 259 | IPR001251 | - | |
| Vifa2g03356 | 268 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 102 | 264 | IPR001251 | - | |
| Vifa2g03356 | 268 | PANTHER | OS03G0850700 PROTEIN | 34 | 267 | - | - | |
| Vifa2g03356 | 268 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 32 | 97 | IPR036273 | - | |
| Vifa2g03356 | 268 | SMART | CRAL_TRIO_N_2 | 62 | 87 | IPR011074 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vifa2g03356 | Vifa-Chr2 | 964143309 | 964144870 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vifa2g03356 | 68 | 254 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 26.667 | 7.71e-12 | 62.4 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vifa2g03356 | - | - | gmx:100797666 | 419.468 |
| Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
|---|---|---|---|---|---|---|---|---|---|
| Vifa2g03356 | 2 | 964143309 | 964144870 | Vifa2g03356 | 2 | 964143309 | 964144870 | ECH | |
| Vifa2g03356 | 2 | 964143309 | 964144870 | Vifa2g03356 | 2 | 964143309 | 964144870 | PCT |